What's new

Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation: 20/06/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation: 20/06/2024, Revision: 3, Status: Authorised

Feb 26, 2025 - 16:33
 0
Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation: 20/06/2024, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation: 20/06/2024, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

STAT+: A bill is reintroduced in Congress to revise provisions in drug-pricing law

Next Article

Clean Simple Eats launches protein soda

Related Posts

Clinical Trial Information System (CTIS) evaluation tim...

Feb 27, 2025  0

Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 64, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 24, 2025  0

Human medicines European public assessment report (EPAR): Omlyclo, omalizumab, Date of authorisation: 16/05/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0